⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVO News
CervoMed Inc. Common Stock
ROTH to Host 5th Annual Healthcare Opportunities Conference on September 29 in New York City
globenewswire.com
ANVS
CRVO
MGNX
MNOV
CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026
globenewswire.com
CRVO
CervoMed to Participate in September Investor Conferences
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO